ITEM METADATA RECORD
Title: CLINICAL BENEFIT WITH REGORAFENIB ACROSS SUBGROUPS AND POST-PROGRESSION IN PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) AFTER PROGRESSION ON IMATINIB (IM) AND SUNITINIB (SU): PHASE 3 GRID TRIAL UPDATE
Authors: Casali, P. G
Reichardt, P
Kang, Y
Blay, J
Rutkowski, P
Gelderblom, H
Hohenberger, P
Leahy, M
von Mehren, M
Joensuu, H
Badalamenti, G
Blackstein, M
Le Cesne, A
Schöffski, Patrick
Maki, R
Xu, Jie
Nishida, T
Kuss, I
Laurent, D
Demetri, G. D #
Issue Date: 2012
Publisher: OXFORD UNIV PRESS
Host Document: ANNALS OF ONCOLOGY vol:23 pages:478-479
Conference: 37th Congress of the European-Society-for-Medical-Oncology (ESMO) location:Vienna: AUSTRIA date:SEP 28-OCT 02, 2012
ISSN: 0923-7534
Publication status: published
KU Leuven publication type: IMa
Appears in Collections:Laboratory of Experimental Oncology
# (joint) last author

Files in This Item:

There are no files associated with this item.

 


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science